The health sector is a vital industry that has a significant impact on people’s well-being, the economy’s competitiveness, and society’s resilience to crises. Finland has the potential to become a global leader in health research, but current policies do not adequately address the industry’s needs.
Finland could attract a larger share of the 40 billion euros invested in drug research in Europe each year by focusing on research and development in the health sector. Despite being known for green technology, the importance of the health sector to Finland’s economy is often overshadowed.
To maximize the potential of the health sector in Finland, incentives for commercializing research results and promoting collaboration between universities, researchers, and companies need to be strengthened. By harnessing the expertise of various stakeholders and fostering innovation, Finland can establish itself as a leader in health research on the global stage.
Research and development are essential for pharmaceutical companies, but stronger national coordination and understanding of the industry’s ecosystem are needed to attract investments. Collaboration between companies, research institutes, and universities is crucial for innovation and success in global competition.
Increasing research investments in the pharmaceutical industry has wide-ranging benefits, including creating high-skilled jobs, generating tax revenues, and improving people’s well-being. Research in the medical field is an investment in the future, with returns that benefit patients and society as a whole.
